3D Bioprinting Market Set for Prosperity in Future

The global 3D bioprinting market is projected to reach a value of $792.5 million in 2022, witnessing a
CAGR of 35.9% during the forecast period (2016–2022).
The market is registering growth due to the high demand for tissues and organs for transplantation,
technological advancements and innovations, and rising compliance for drug discovery processes. 3D
bioprinting is an additive manufacturing technology and refers to the process of creating 3D structures
by making use of live cells. The process utilizes 3D printing technologies for creating live tissue or cell
structures.
In terms of technology, the 3Dbioprinting market is categorized into pneumatic extrusion, laser-based,
syringe-based, inkjet-based, and others. Among these, the syringe-based category dominated the
market during the historical period (2012–2015) and is further predicted to account for the largest share
of the market during the forecast period, contributing a share of over 35.0% in 2022. The pneumatic
extrusion category is expected to grow at the fastest pace during the forecast period due to the
advantageous features of this technology, as compared to the other technologies.
Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/3dbioprinting-market/report-sample
When application is taken into consideration, the 3Dbioprinting market is divided into pharmaceutical,
tissue & organ regeneration, 3D cell culture, and others. Out of these, the tissue & organ regeneration
application dominated the market during the historical period and is further predicted to account for
the largest revenue share of more than 55.0% in 2022. The 3D cell culture category is expected to
witness the fastest growth during the forecast period. This is because extensive research is being carried
out in the field of stem cell around the world.
Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiryurl=3d-bioprinting-market
The surging requirement for organs and tissues for transplantation is another major factor driving the
3D bioprinting market. There is a huge gap between the demand and supply of tissues and organs
around the world. Several organs such as lung, heart, intestine, kidney, pancreas, and liver are required
for patients who have non-functioning organs. The organ donation rates are low while the demand for
new tissues and organs is surging. 3D bioprinting is capable of developing organs and tissues, which is
why the research & development activities in this domain are increasing.
Hence, the market is expanding due to the growing compliance for drug delivery processes and
increasing demand for tissues and organs for transplantation.
© P&S Intelligence. All rights reserved Page 2